OAB and Incontinence

>

Latest News

Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Better evidence for efficacy of postmenopausal incontinence treatments needed

May 14th 2024

Urinary symptoms were not significantly improved from local estrogen use in most studies, though an improvement in vaginal symptoms was observed.

FDA accepts sNDA for vibegron for OAB symptoms in pharmacologically treated BPH
FDA accepts sNDA for vibegron for OAB symptoms in pharmacologically treated BPH

May 13th 2024

EMA recommends approval of vibegron for OAB
EMA recommends approval of vibegron for OAB

April 29th 2024

AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder

April 25th 2024

Published OASIS trial data show safety, efficacy of Revi system for OAB
Published OASIS trial data show safety, efficacy of Revi system for OAB

April 23rd 2024

© 2024 MJH Life Sciences

All rights reserved.